Trump pick to lead FDA was architect of Joe Rogan-backed policy to promote psychedelics

The Daily Mail reported that a Trump nominee to lead the FDA was instrumental in a policy promoting psychedelics. Joe Rogan had previously brought the subject of psychedelics to President Trump's attention via text, citing statistics on ibogaine's potential to combat opioid addiction.
healthcarepharmaceuticalsgovernment
Impact Score
7/10